Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation.
暂无分享,去创建一个
C. Bruni | L. Chiariotti | T. Angrisano | R. Pero | F. Lembo | C. Tuccillo | R. Tomaiuolo | S. Sacchetti | S. Peluso | S. Keller | Silvia Peluso | Raffaela Pero
[1] P. Cossart,et al. Histone modifications and chromatin remodeling during bacterial infections. , 2008, Cell host & microbe.
[2] Vladimir Benes,et al. Transient cyclical methylation of promoter DNA , 2008, Nature.
[3] T. A. Nagy,et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. , 2008, Cancer research.
[4] C. McCall,et al. Epigenetic Silencing of Tumor Necrosis Factor α during Endotoxin Tolerance* , 2007, Journal of Biological Chemistry.
[5] A. Andriulli,et al. Aberrant DNA Methylation in Non-Neoplastic Gastric Mucosa of H. Pylori Infected Patients and Effect of Eradication , 2007, The American Journal of Gastroenterology.
[6] S. Berger. The complex language of chromatin regulation during transcription , 2007, Nature.
[7] M. Fraga,et al. The Polycomb group protein EZH2 directly controls DNA methylation , 2007, Nature.
[8] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[9] J. Basu,et al. TLR4-Dependent NF-κB Activation and Mitogen- and Stress-Activated Protein Kinase 1-Triggered Phosphorylation Events Are Central to Helicobacter pylori Peptidyl Prolyl cis-, trans-Isomerase (HP0175)-Mediated Induction of IL-6 Release from Macrophages1 , 2006, The Journal of Immunology.
[10] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[11] M. Fraga,et al. The Polycomb group protein EZH2 directly controls DNA methylation , 2006, Nature.
[12] A. Kaneda,et al. High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.
[13] T. Kuzuhara,et al. Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomach. , 2006, Journal of biochemistry and molecular biology.
[14] John K Field,et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Liwu Li,et al. Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-κB Transactivation at the IL-1β Promoter1 , 2005, The Journal of Immunology.
[16] Jaw-Town Lin,et al. Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-κB Activation , 2004, Molecular Pharmacology.
[17] Xiao Yu Chen,et al. Development of gastric adenocarcinoma in Mongolian gerbils after long‐term infection with Helicobacter pylori , 2004, Journal of gastroenterology and hepatology.
[18] J. Christman,et al. Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[19] A. Knox,et al. Transcriptional Regulation of Cyclooxygenase 2 by Bradykinin and Interleukin-1β in Human Airway Smooth Muscle Cells: Involvement of Different Promoter Elements, Transcription Factors, and Histone H4 Acetylation , 2003, Molecular and Cellular Biology.
[20] C. Buskens,et al. Cyclooxygenase‐2 and gastric carcinogenesis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[21] M. Blaser,et al. Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype. , 2003, The Journal of infectious diseases.
[22] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[23] C. Allis,et al. Translating the Histone Code , 2001, Science.
[24] B. Rossi,et al. Epithelial Intestinal Cell Apoptosis Induced byHelicobacter pylori Depends on Expression of thecag Pathogenicity Island Phenotype , 2001, Infection and Immunity.
[25] M. Blaser,et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. , 2000, Journal of the National Cancer Institute.
[26] T. Fujita,et al. Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[27] H. S. Kim,et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] C. Prinz,et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Meltzer,et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. , 1999, Gastroenterology.
[30] H. P. Wang,et al. Helicobacter pylori infection and age on the development of intestinal metaplasia--a multiple logistic regression analysis. , 1998, Hepato-gastroenterology.
[31] C. Bruni,et al. Helicobacter pylori Up-regulates Cyclooxygenase-2 mRNA Expression and Prostaglandin E2 Synthesis in MKN 28 Gastric Mucosal Cells in Vitro * , 1998, The Journal of Biological Chemistry.
[32] H. Nagai,et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.
[33] N. Talley,et al. Helicobacter pylori Infection and Gastric Neoplasia: Correlations With Histological Gastritis and Tumor Histology , 1998, American Journal of Gastroenterology.
[34] W. Quint,et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. , 1998, Gastroenterology.
[35] F. Doran,et al. Relationship of Helicobacter pylori infection to several malignant and non-malignant gastrointestinal diseases. , 1997, Journal of experimental & clinical cancer research : CR.
[36] M. Blaser,et al. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.
[37] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[38] J. Parsonnet,et al. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. , 1991, Journal of the National Cancer Institute.
[39] M. Blaser,et al. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity , 1990, Infection and immunity.
[40] M. Razandi,et al. Human cell line for study of damage to gastric epithelial cells in vitro. , 1988, The Journal of laboratory and clinical medicine.
[41] T. Motoyama,et al. COMPARISON OF SEVEN CELL LINES DERIVED FROM HUMAN GASTRIC CARCINOMAS , 1986, Acta pathologica japonica.
[42] Albert Jeltsch,et al. Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.
[43] B. Turner,et al. Defining an epigenetic code , 2007, Nature Cell Biology.
[44] C. McCall,et al. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. , 2007, The Journal of biological chemistry.
[45] H. Putter,et al. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] J. Galmiche,et al. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines. , 2005, Anticancer research.
[47] S. Saccani,et al. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. , 2002, Nature immunology.
[48] M. Blaser,et al. Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.
[49] S. Saccani,et al. p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.
[50] A. Hoffmann,et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event , 2001, Nature Immunology.